See more : Shenzhen Techwinsemi Technology Co., Ltd. (001309.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Croda International Plc (COIHY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Croda International Plc, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
You may be interested
- Israel Land Development – Urban Renewal Ltd (ILDR.TA) Income Statement Analysis – Financial Results
- Pepper Food Service Co., Ltd. (3053.T) Income Statement Analysis – Financial Results
- Randstad N.V. (RANJF) Income Statement Analysis – Financial Results
- UUUM Co.,Ltd. (3990.T) Income Statement Analysis – Financial Results
- Carpenter Tan Holdings Limited (0837.HK) Income Statement Analysis – Financial Results
Croda International Plc (COIHY)
About Croda International Plc
Croda International Plc creates, makes, and sells specialty chemicals in Europe, the Middle East, Africa, North America, Asia, and Latin America. It operates through four segments: Consumer Care, Life Sciences, Performance Technologies, and Industrial Chemicals. The company offers adhesives; crop protection additives and adjuvants, seed enhancement and animal health chemicals, chemical bio-stimulants, and specialty additives for agricultural films; and lubricant additives, coatings and polymers, vehicle cleaning chemicals, and products for automotive textiles and fibers, as well as specialty additives for plastics, and battery and catalyst industries. It also provides specialty ingredients for self-tanning, color cosmetics, bath and shower, deodorants, anti-perspirants, depilatories, men's grooming, and oral hygiene, as well as skin, hair, sun, body, and baby care applications; construction chemicals and bitumen additives; dietary supplements; and materials and polymer additives for electronics and devices. In addition, the company offers chemistries, emulsifiers, fuel and power generation additives, and polymer additives; food additives; specialty polymer additives for furniture and wood applications; household, industrial, and institutional cleaning products; lubricants; oleochemicals; and packaging, print, and paper chemicals. Further, it provides paints and coatings; active pharmaceutical ingredients; thermal management products; plastic and rubber products; skin health products; hygiene and industrial nonwovens, botanical extracts, tissues, and textile auxiliaries; and water treatment chemicals. Additionally, the company offers bio-based phase change materials for buildings and ventilation, clothing and healthcare, electronics and devices, food and refrigeration, energy storage and recovery, temperature controlled packaging, and vehicles and automotive applications. The company was incorporated in 1925 and is headquartered in Goole, the United Kingdom.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.69B | 2.09B | 1.89B | 1.39B | 1.38B | 1.39B | 1.37B | 1.24B | 1.08B | 1.05B | 1.08B | 1.05B | 1.07B | 1.00B | 827.50M | 911.10M | 804.80M | 480.10M | 305.60M | 280.90M | 303.40M | 313.60M | 312.40M | 365.90M | 371.80M | 375.30M | 429.10M | 447.60M | 458.80M | 423.00M | 415.10M | 362.90M | 352.50M | 366.40M | 373.80M | 348.80M | 339.47M | 342.73M | 407.15M |
| Cost of Revenue | 964.50M | 1.10B | 950.70M | 758.20M | 865.50M | 864.60M | 855.70M | 798.50M | 704.10M | 703.00M | 713.90M | 694.60M | 721.10M | 684.40M | 611.50M | 698.70M | 617.90M | 352.80M | 214.50M | 198.00M | 224.70M | 236.70M | 239.30M | 278.30M | 285.70M | 297.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 730.00M | 985.60M | 938.90M | 632.10M | 512.20M | 522.30M | 517.40M | 445.10M | 377.60M | 343.60M | 363.10M | 357.30M | 347.30M | 317.50M | 216.00M | 212.40M | 186.90M | 127.30M | 91.10M | 82.90M | 78.70M | 76.90M | 73.10M | 87.60M | 86.10M | 78.30M | 429.10M | 447.60M | 458.80M | 423.00M | 415.10M | 362.90M | 352.50M | 366.40M | 373.80M | 348.80M | 339.47M | 342.73M | 407.15M |
| Gross Profit Ratio | 43.08% | 47.17% | 49.69% | 45.47% | 37.18% | 37.66% | 37.68% | 35.79% | 34.91% | 32.83% | 33.71% | 33.97% | 32.51% | 31.69% | 26.10% | 23.31% | 23.22% | 26.52% | 29.81% | 29.51% | 25.94% | 24.52% | 23.40% | 23.94% | 23.16% | 20.86% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 66.30M | 58.70M | 38.20M | 37.60M | 37.50M | 37.50M | 34.60M | 25.00M | 22.70M | 22.30M | 19.60M | 23.90M | 21.00M | 21.10M | 17.60M | 14.10M | 12.10M | 8.90M | 7.30M | 6.80M | 6.10M | 6.10M | 7.20M | 7.00M | 7.10M | 8.00M | 8.40M | 8.70M | 7.60M | 7.20M | 6.10M | 6.00M | 5.20M | 5.10M | 4.50M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 405.30M | 439.10M | 407.70M | 270.40M | 126.40M | 127.70M | 117.30M | 100.00M | 75.50M | 62.30M | 61.70M | 65.30M | 66.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 24.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 77.20M | 101.80M | 93.00M | 71.70M | 65.90M | 65.80M | 74.10M | 59.50M | 40.30M | 38.90M | 38.10M | 36.60M | 38.40M | 42.30M | 40.30M | 45.80M | 45.30M | 25.10M | 15.10M | 13.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 482.50M | 540.90M | 500.70M | 342.10M | 192.30M | 193.50M | 191.40M | 159.50M | 115.80M | 101.20M | 99.80M | 101.90M | 38.40M | 42.30M | 40.30M | 45.80M | 45.30M | 25.10M | 15.10M | 38.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | -36.10M | 6.40M | -16.00M | -11.00M | 0.00 | 0.00 | 3.30M | -1.20M | 0.00 | 0.00 | 0.00 | 39.10M | 53.10M | 33.10M | -100.00K | -100.00K | 1.20M | 1.40M | -7.90M | -1.50M | -800.00K | 34.00M | 48.00M | 29.00M | 12.50M | 378.30M | 384.10M | 391.30M | 371.60M | 377.30M | 321.10M | 318.30M | 359.60M | 367.90M | 346.20M | 186.00K | 228.00K | 181.00K |
| Operating Expenses | 482.50M | 504.80M | 507.10M | 326.10M | 181.30M | 193.50M | 191.40M | 159.50M | 115.80M | 101.20M | 99.80M | 101.90M | 104.90M | 118.90M | 94.50M | 99.80M | 103.90M | 68.90M | 40.00M | 37.90M | 262.30M | 275.20M | 40.10M | 55.20M | 36.00M | 19.60M | 386.30M | 392.50M | 400.00M | 379.20M | 384.50M | 327.20M | 324.30M | 364.80M | 373.00M | 350.70M | 339.85M | 343.19M | 407.51M |
| Cost & Expenses | 1.45B | 1.61B | 1.46B | 1.08B | 1.05B | 1.06B | 1.05B | 958.00M | 819.90M | 804.20M | 813.70M | 796.50M | 826.00M | 803.30M | 706.00M | 798.50M | 721.80M | 421.70M | 254.50M | 235.90M | 262.30M | 275.20M | 279.40M | 333.50M | 321.70M | 316.60M | 386.30M | 392.50M | 400.00M | 379.20M | 384.50M | 327.20M | 324.30M | 364.80M | 373.00M | 350.70M | 339.85M | 343.19M | 407.51M |
| Interest Income | 14.80M | 5.10M | 1.50M | 500.00K | 900.00K | 1.10M | 600.00K | 700.00K | 700.00K | 800.00K | 1.30M | 7.10M | 10.00M | 4.40M | 2.20M | 9.20M | 8.90M | 6.10M | 1.90M | 1.50M | 1.60M | 1.10M | 1.10M | 1.00M | 500.00K | 600.00K | 700.00K | 600.00K | 500.00K | 500.00K | 400.00K | 400.00K | 600.00K | 800.00K | 1.80M | 1.50M | 1.28M | 575.00K | 1.16M |
| Interest Expense | 25.90M | 8.30M | 25.70M | 21.00M | 18.50M | 12.10M | 12.50M | 10.60M | 10.20M | 13.80M | 14.50M | 9.30M | 10.20M | 10.70M | 15.70M | 25.50M | 31.10M | 13.30M | 3.80M | 3.40M | 2.90M | 4.00M | 6.40M | 9.50M | 7.70M | 8.30M | 7.20M | 5.20M | 5.20M | 3.70M | 5.10M | 5.80M | 6.70M | 4.00M | 3.80M | 2.50M | 2.39M | 2.50M | 5.35M |
| Depreciation & Amortization | 126.20M | 120.70M | 113.30M | 81.80M | 66.40M | 56.20M | 53.30M | 49.20M | 38.50M | 37.00M | 33.90M | 31.10M | 32.70M | 34.10M | 32.40M | 30.90M | 28.60M | 19.20M | 14.00M | 14.10M | 14.60M | 15.70M | 15.20M | 14.90M | 19.10M | 18.20M | 18.30M | 16.60M | 15.70M | 14.10M | 13.10M | 11.60M | 11.20M | 9.90M | 8.20M | 8.20M | 7.66M | 7.72M | 7.24M |
| EBITDA | 388.40M | 554.50M | 550.50M | 372.30M | 387.20M | 386.10M | 379.90M | 335.50M | 301.00M | 280.20M | 298.50M | 287.20M | 278.70M | 237.10M | 142.10M | 152.60M | 117.80M | 50.80M | 68.40M | 60.60M | 62.10M | 56.50M | 55.80M | 72.80M | 51.60M | 59.80M | 64.70M | 68.60M | 60.90M | 60.60M | 67.10M | 47.20M | 39.20M | 47.60M | 48.40M | 46.30M | 41.84M | 37.36M | 35.46M |
| EBITDA Ratio | 22.92% | 26.54% | 28.93% | 27.93% | 28.90% | 27.84% | 27.67% | 26.98% | 27.83% | 26.77% | 27.72% | 27.91% | 26.68% | 23.67% | 18.86% | 16.75% | 14.96% | 17.68% | 22.38% | 21.57% | 19.08% | 18.02% | 17.48% | 17.44% | 18.37% | 15.93% | 15.73% | 15.33% | 13.27% | 13.81% | 13.73% | 13.14% | 11.35% | 13.43% | 13.16% | 12.73% | 12.33% | 10.90% | 8.71% |
| Operating Income | 247.50M | 444.70M | 438.20M | 290.00M | 319.90M | 328.80M | 326.00M | 285.60M | 261.80M | 242.40M | 263.30M | 255.40M | 242.40M | 198.60M | 104.30M | 112.60M | 77.40M | 26.70M | 52.50M | 45.00M | 39.40M | 38.10M | 34.20M | 41.40M | 33.40M | 39.40M | 40.00M | 51.20M | 44.10M | 46.00M | 40.70M | 35.20M | 27.40M | 1.60M | 800.00K | -1.90M | -372.00K | -456.00K | -362.00K |
| Operating Income Ratio | 14.61% | 21.28% | 23.19% | 20.86% | 23.22% | 23.71% | 23.74% | 22.97% | 24.20% | 23.16% | 24.45% | 24.28% | 22.69% | 19.82% | 12.60% | 12.36% | 9.62% | 5.56% | 17.18% | 16.02% | 12.99% | 12.15% | 10.95% | 11.31% | 8.98% | 10.50% | 9.32% | 11.44% | 9.61% | 10.87% | 9.80% | 9.70% | 7.77% | 0.44% | 0.21% | -0.54% | -0.11% | -0.13% | -0.09% |
| Total Other Income/Expenses | -11.20M | 335.30M | -26.70M | -20.50M | -17.60M | -13.10M | -11.90M | -9.90M | -9.50M | -13.00M | -13.20M | -16.60M | -4.90M | -6.30M | -13.50M | -16.30M | -22.20M | -9.50M | -1.90M | -1.90M | 3.80M | -31.90M | 0.00 | 7.00M | -8.60M | -25.40M | -800.00K | -8.30M | -18.80M | -3.20M | 8.20M | -5.40M | -6.10M | 32.10M | 35.60M | 37.50M | 32.17M | 27.59M | 23.24M |
| Income Before Tax | 236.30M | 780.00M | 411.50M | 269.50M | 302.30M | 317.80M | 314.10M | 275.70M | 252.30M | 229.40M | 250.10M | 253.20M | 242.20M | 192.30M | 90.80M | 96.20M | 55.10M | 17.10M | 50.60M | 43.10M | 43.00M | 7.60M | 34.20M | 48.40M | 24.80M | 14.00M | 39.20M | 42.90M | 25.30M | 42.80M | 48.90M | 29.80M | 21.30M | 33.70M | 36.40M | 35.60M | 31.80M | 27.14M | 22.88M |
| Income Before Tax Ratio | 13.95% | 37.33% | 21.78% | 19.38% | 21.94% | 22.91% | 22.88% | 22.17% | 23.32% | 21.92% | 23.22% | 24.07% | 22.67% | 19.19% | 10.97% | 10.56% | 6.85% | 3.56% | 16.56% | 15.34% | 14.17% | 2.42% | 10.95% | 13.23% | 6.67% | 3.73% | 9.14% | 9.58% | 5.51% | 10.12% | 11.78% | 8.21% | 6.04% | 9.20% | 9.74% | 10.21% | 9.37% | 7.92% | 5.62% |
| Income Tax Expense | 64.20M | 126.70M | 88.70M | 67.90M | 78.50M | 79.50M | 77.40M | 78.10M | 71.20M | 64.20M | 72.20M | 78.10M | 76.30M | 62.50M | 33.20M | 31.50M | 18.70M | 10.70M | 17.60M | 15.20M | 13.70M | 8.00M | 12.80M | 16.10M | 11.50M | 11.10M | 12.60M | 13.60M | 11.30M | 12.10M | 12.20M | 9.60M | 6.90M | 10.90M | 11.10M | 10.70M | 9.94M | 9.59M | 8.77M |
| Net Income | 171.00M | 649.30M | 320.80M | 201.60M | 223.90M | 238.50M | 237.00M | 196.70M | 180.70M | 165.30M | 177.50M | 151.00M | 167.50M | 130.80M | 23.80M | 61.00M | 87.30M | 8.00M | 32.70M | 30.60M | 29.40M | -500.00K | 21.30M | 32.20M | 13.00M | 2.60M | 26.20M | 29.00M | 13.80M | 30.40M | 36.30M | 20.00M | 14.20M | 19.80M | 24.30M | 24.80M | 20.32M | 17.64M | 11.59M |
| Net Income Ratio | 10.09% | 31.08% | 16.98% | 14.50% | 16.25% | 17.20% | 17.26% | 15.82% | 16.71% | 15.79% | 16.48% | 14.35% | 15.68% | 13.06% | 2.88% | 6.70% | 10.85% | 1.67% | 10.70% | 10.89% | 9.69% | -0.16% | 6.82% | 8.80% | 3.50% | 0.69% | 6.11% | 6.48% | 3.01% | 7.19% | 8.74% | 5.51% | 4.03% | 5.40% | 6.50% | 7.11% | 5.98% | 5.15% | 2.85% |
| EPS | 1.22 | 4.66 | 2.30 | 1.55 | 1.73 | 0.93 | 0.93 | 0.76 | 0.71 | 0.65 | 0.70 | 0.64 | 0.66 | 0.51 | 0.09 | 0.24 | 0.34 | 0.03 | 0.14 | 0.12 | 0.12 | 0.00 | 0.09 | 0.13 | 0.05 | 0.01 | 0.10 | 0.11 | 0.05 | 0.12 | 0.15 | 0.08 | 0.06 | 0.08 | 0.10 | 0.10 | 0.09 | 0.07 | 0.05 |
| EPS Diluted | 1.22 | 4.65 | 2.29 | 1.55 | 1.72 | 0.92 | 0.92 | 0.75 | 0.70 | 0.64 | 0.69 | 0.63 | 0.65 | 0.50 | 0.09 | 0.24 | 0.34 | 0.03 | 0.13 | 0.12 | 0.12 | 0.00 | 0.09 | 0.13 | 0.05 | 0.01 | 0.10 | 0.11 | 0.05 | 0.12 | 0.15 | 0.08 | 0.06 | 0.08 | 0.10 | 0.10 | 0.09 | 0.07 | 0.05 |
| Weighted Avg Shares Out | 139.60M | 139.40M | 139.50M | 130.00M | 129.60M | 256.69M | 255.93M | 259.13M | 255.54M | 255.62M | 255.03M | 253.90M | 255.06M | 258.84M | 256.73M | 256.73M | 256.73M | 256.73M | 241.56M | 253.13M | 245.48M | 235.63M | 246.94M | 247.70M | 251.47M | 256.37M | 254.67M | 252.60M | 250.71M | 248.83M | 246.94M | 245.06M | 243.17M | 241.29M | 242.23M | 239.85M | 238.17M | 237.90M | 237.88M |
| Weighted Avg Shares Out (Dil) | 139.80M | 139.70M | 139.80M | 130.20M | 129.90M | 258.12M | 258.50M | 261.42M | 257.47M | 257.10M | 257.18M | 257.33M | 259.66M | 262.02M | 259.33M | 257.40M | 258.45M | 256.73M | 245.36M | 253.13M | 245.48M | 235.63M | 246.94M | 247.70M | 251.47M | 256.37M | 256.56M | 252.60M | 250.71M | 248.83M | 246.94M | 245.06M | 243.17M | 241.29M | 242.23M | 239.85M | 238.17M | 237.90M | 237.88M |
SkinBioTherapeutics receives Croda boost
Shares in SkinBioTherapeutics PLC (AIM:SBTX) rose 6% after the company confirmed it had finalised terms with Croda PLC for the commercial launch of its SkinBiotix technology. The agreement includes royalties based on global sales of products developed using SkinBiotix.
Croda slumps on chemical ban fears under Trump health head
Croda International PLC (LSE:CRDA) shares faced a blow on Friday in the wake of Robert F Kennedy Junior's appointment as US health secretary by president-elect Donal Trump. Shares in the London-listed chemicals firm dipped 2.9% over the course of the...
Croda International Plc (COIHF) Q2 2024 Earnings Call Transcript
Croda International Plc (OTCPK:COIHF) Q2 2024 Earnings Conference Call July 30, 2024 4:00 AM ET Company Participants Steve Foots - Group Chief Executive Anthony Fitzpatrick - Interim Chief Financial Officer and President Strategy, Corporate Development and Industrial Specialties David Bishop...
Croda poaches Johnson Matthey finance chief
Croda International PLC (LSE:CRDA), the chemicals maker, has traded flat this morning despite having announced it poached finance chief Stephen Oxley from rival Johnson Matthey PLC (LSE:JMAT). Oxley will become CFO at Croda by no later than April 1 2025,...
Croda profits tumble on group-wide destocking
Chemicals group Croda saw profits tumble in the year just ended as sales were hit by widespread destocking and a weak economic backdrop. All three divisions posted lower revenues with the industrial specialities the worst hit by destocking and registering...
abrdn and Croda both need an uplift from tomorrow's update
Fund manager Abrdn's problems led to 500 job cuts in January to save costs
Croda predicted to have another 'down' year in 2024, says this investment bank
Analysts at Deutsche Bank are predicting a gloomy outlook for UK-based chemical company Croda International PLC (LSE:CRDA). Investment bank analyst Virginie Boucher-Ferte said in a research note on Friday that Croda, which is not due to release its results until...
Croda shares hit as Estee Lauder slashes guidance due to China, Middle East effects
Croda International PLC (LSE:CRDA) shares slipped around 3.4% on Wednesday after US giant Estee Lauder Companies Inc (NYSE:EL) slashed its profit forecast. In US pre-market trading Estee stock tumbled 14% after the cosmetics manufacturer released first-quarter earnings that saw it slash its...
Nobel for mRNA: Which other biotech stocks might be overlooked?
Scientists Katalin Karikó and Drew Weissman were awarded the Nobel prize this week for a discovery that went under the radar for many years, until it was found to hold the key to stabilising mRNA vaccines used in the fight against the Covid-19...
Croda International Has Growth and Value Potential
Founded in 1925, Croda International PLC ( LSE:CRDA , Financial) ( COIHF , Financial) produces ingredients for various industries, including consumer cosmetics, pharmaceuticals and agriculture. The company sells its products to manufacturers who use them for their own products.
Source: https://incomestatements.info
Category: Stock Reports